Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
Devendra Kumar, Neerja Trivedi
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111642-111642
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Molnupiravir: A new candidate for COVID‐19 treatment
Fariba Pourkarim, Samira Pourtaghi‐Anvarian, Haleh Rezaee
Pharmacology Research & Perspectives (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 110
Molnupiravir and Its Antiviral Activity Against COVID-19
Lili Tian, Zehan Pang, Maochen Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 102
Antifungal Drugs TDM: Trends and Update
Benjamin Kably, Manon Launay, Audrey Derobertmasure, et al.
Therapeutic Drug Monitoring (2021) Vol. 44, Iss. 1, pp. 166-197
Closed Access | Times Cited: 48
A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies
Changxing Li, Sobia Noreen, Lixue Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112550-112550
Open Access | Times Cited: 41
Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19
Mohamed Mahdi, Levente Hermán, János Réthelyi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3812-3812
Open Access | Times Cited: 33
Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
Paul Andrei Negru, Andrei-Flavius Radu, Cosmin Mihai Vesa, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112700-112700
Open Access | Times Cited: 27
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
Linda Brunotte, Shuyu Zheng, Angeles Mecate‐Zambrano, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1400-1400
Open Access | Times Cited: 37
PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19
B. Rabindran Jermy, Vijaya Ravinayagam, Dana Almohazey, et al.
Applied Clay Science (2021) Vol. 216, pp. 106333-106333
Open Access | Times Cited: 32
The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients
Qiaoqiao Zhou, Lei Zhang, Yanming Dong, et al.
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 375-384
Open Access | Times Cited: 14
First electropolymerized carbidopa-based molecularly imprinted film: Disposable electrochemical sensor for monitoring of anti-COVID-19 drug favipiravir in human plasma
Hend Z. Yamani, Noha F. El Azab
Microchemical Journal (2023) Vol. 196, pp. 109572-109572
Closed Access | Times Cited: 14
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 21
Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals
Sana Eybpoosh, Alireza Biglari, Rahim Sorouri, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011744-e1011744
Open Access | Times Cited: 11
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
Sharoen Yu Ming Lim, Basel Al Bishtawi, Willone Lim
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 3, pp. 221-240
Open Access | Times Cited: 10
Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms
Golnaz Taheri, Mahnaz Habibi
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening
Shumeng Ma, Shymaa Damfo, Jiaqi Lou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12448-12448
Open Access | Times Cited: 16
A Multidisciplinary Approach to Coronavirus Disease (COVID-19)
Aliye Gediz Ertürk, Arzu Şahin, Ebru Batı Ay, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3526-3526
Open Access | Times Cited: 19
An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)
Pasquale Pagliano, Carmine Sellitto, Giuliana Scarpati, et al.
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 1, pp. 9-18
Open Access | Times Cited: 18
Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID‐19
Liyan Zeng, Rui Chen, Xuhua Jiang, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 4, pp. 767-779
Closed Access | Times Cited: 2
Comparative Analysis of the Interaction between the Antiviral Drug Umifenovir and Umifenovir Encapsulated in Phospholipids Micelles (Nanosome/Umifenovir) with dsDNA as a Model for Pharmacogenomic Analysis by Electrochemical Methods
Victoria V. Shumyantseva, Tatiana V. Bulko, Lyubov E. Agafonova, et al.
Processes (2023) Vol. 11, Iss. 3, pp. 922-922
Open Access | Times Cited: 6
SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues
Chukwunonso K. Nwabufo, Md. Tozammel Hoque, Lily Yip, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
The need for a multi-level drug targeting strategy to curb the COVID-19 pandemic
George J. Kontoghiorghes, Stella Fetta, Christina Kontoghiorghe
Frontiers in Bioscience-Landmark (2021) Vol. 26, Iss. 12
Open Access | Times Cited: 14
EFFECTS OF STRESS IN PREGNANCY ON PRENATAL ATTACHMENT, AND CONTRIBUTING FACTORS
Yasemin Şanlı, Nuran Nur Aypar Akbağ
Psychiatria Danubina (2022) Vol. 34, Iss. 1, pp. 25-33
Open Access | Times Cited: 10
The influence of SARS‐CoV‐2 infection on expression of drug‐metabolizing enzymes and transporters in a hACE2 murine model
Kiran Deshpande, Keith R. Lange, William B. Stone, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 5
Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy
Norma Torres‐Carrillo, Erika Martínez‐López, Nora Magdalena Torres-Carrillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17100-17100
Open Access | Times Cited: 5
Old Problem, New Concerns: Hypercortisolemia in the Time of COVID-19
Agata Berlińska, Renata Świątkowska‐Stodulska, Krzysztof Sworczak
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top